155P Safety and efficacy of niraparib in Japanese recurrent ovarian cancer patients: Maintenance therapy for platinum-sensitive recurrence and late-line monotherapy

S. Fujiwara; M. Shimada; H. Nomura; H. Kajiyama; T. Kagimura; A. Kato; T. Kuroda; R. Murakami; T. Chiyoda; M. Kamata; T. Ohta; H. Nakai; Y. Takei; K. Yokosu; H. Kobara; S. Shigeta; A. Okamoto

doi:10.1016/j.esmoop.2026.108202

July 1, 2026ESMO OpenOpen Access

155P Safety and efficacy of niraparib in Japanese recurrent ovarian cancer patients: Maintenance therapy for platinum-sensitive recurrence and late-line monotherapy

View Full Paper

Ask AI

Bookmark

Share

Key Points

This interim analysis aims to evaluate the safety and efficacy of niraparib in Japanese patients with recurrent ovarian cancer.
Conducted an interim analysis of patient characteristics and treatment status.
Evaluated safety outcomes during the first 6 months of niraparib therapy.
Safety outcomes were monitored and reported for the duration of the therapy, showing relevant data on patient responses.

Implication

Interim analysis details safety outcomes of niraparib in Japanese ovarian cancer patients, suggesting potential benefits.

Abstract

Real-world data on niraparib in Japanese patients are limited. This interim analysis describes patient characteristics, treatment status, and safety outcomes during the first 6 months of niraparib therapy.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Fujiwara et al. (2026) studied this question.

synapsesocial.com/papers/6a48a42489561a0c2d78daae https://doi.org/10.1016/j.esmoop.2026.108202

View Full Paper

Ask AI

Bookmark

Share

155P Safety and efficacy of niraparib in Japanese recurrent ovarian cancer patients: Maintenance therapy for platinum-sensitive recurrence and late-line monotherapy

Key Points

Implication

Abstract

Discussion

Cite This Study

155P Safety and efficacy of niraparib in Japanese recurrent ovarian cancer patients: Maintenance therapy for platinum-sensitive recurrence and late-line monotherapy

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

More related papers

More from ESMO Open

Keep reading

More related papers

More from ESMO Open